(Q37210054)

19 August 2017

Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast (English)

1 reference

19 August 2017

1 reference

1 reference

Quinn CM

1

1 reference

PMCID

500068

19 August 2017

Ostrowski JL

series ordinal

2

1 reference

PMCID

500068

19 August 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

50

1 reference

19 August 2017

596-599

1 reference

19 August 2017

7

1 reference

Flow cytometric and histological analysis of ductal carcinoma in situ of the breast

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in-situ of the breast; second EORTC consensus meeting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in situ: a proposal for a new classification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Duct carcinoma in situ. Pathology and treatment

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500068

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers

26 June 2018

1 reference

12 December 2020

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

12 December 2020

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

12 December 2020

DNA analysis of ductal carcinoma in situ of the breast. A comparison with histologic features

1 reference

12 December 2020

Estrogen receptor immunohistochemistry in carcinoma in situ of the breast

1 reference

12 December 2020

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

12 December 2020

The classification of ductal carcinoma in situ and its association with biological markers

1 reference

12 December 2020

Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component

1 reference

12 December 2020

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

12 December 2020

Comparison of cytomorphological and architectural heterogeneity in mammographically-detected ductal carcinoma in situ

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.50.7.596

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMCID

500068